BDB advising Bioquell plc on its takeover by Ecolab Inc.

BDB is advising Bioquell plc in connection with its takeover by Ecolab U.S. 2 Inc., a wholly-owned subsidiary of Ecolab Inc.. Bioquell is a UK-based leading provider of specialist hydrogen peroxide vapour bio-decontamination equipment, modular isolators and associated services for the life sciences and healthcare sectors. Ecolab is a US listed global leader in water, hygiene and energy technologies and services.

The recommended all cash offer of 590p per share, values Bioquell at approximately £140.51 million. The offer is to be effected by means of a court-sanctioned scheme of arrangement and is supported by shareholders representing 55.10% of the ordinary share capital (through irrevocable undertakings and a letter of intent).

The team acting on this transaction was led by corporate partner Nick McCarthy and legal director Tessa Trevelyan Thomas, assisted by associates Rebecca Arnheim, Annabel Doneley and Caroline Carter.